Found 5 matching trials
To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis
PHASE3This is a Phase 3 Study to Compare Pharmacokinetics, Efficacy and Safety of...
Location
CT-P17 3.3 investigational site
Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)
PHASE1This study has been designed as a multicentre, randomised, double-blind stu...
Location
Scientia Clinical Research
Comparative Safety, Tolerability, Pharmacokinetic Study of AVT02 (100MG/ML) and Humira (100MG/ML) in Healthy Volunteers
PHASE1Adalimumab is an immunosuppressive drug that belongs to the family of anti-...
To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects
PHASE1This is a Phase 1, Randomized, Double-blind, Three-arm, Parallel group, Sin...
Location
CHA Bundang Medical Center
MSB11022 in Healthy Subjects
PHASE1This is a phase I, randomized, double-blind, parallel-group trial to compar...
Location
Multiple Locations